Clinical Trial Update: Comparison of Pom and Dex in Subjects With RRMM Previously Treated With Len and a PI Dara/Pom/Dex vs Pom/Dex [Phase 3]

View source ↗

Summary

Phase 3 trial in relapsed/refractory multiple myeloma comparing daratumumab/pomalidomide/dexamethasone versus pomalidomide/dexamethasone; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)
• DEXAMETHASONE (Dexamethasone)
• Pomalyst (pomalidomide)

Snippet

Sponsor: Stichting European Myeloma Network | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2022-05-11